Ironing Out the Fine Points Of Endometriosis Trial Design
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Given the paucity of drugs to treat endometriosis and uterine fibroids, it is not surprising that FDA is still feeling out the regulatory standards. Neurocrine and Abbott are testing endpoints along the way.